Abstract:The metabolisms of five xanthones isolated from a Tibetan medicinal herb Halenia elliptica D. Don, including 1-hydroxy-2,3,5-trimethoxy-xanthone (HM-1), 1-hydroxy-2,3,4,7-tetramethoxy-xanthone (HM-2), 1-hydroxy-2,3,4,5-tetramethoxy-xanthone (HM-3), 1,7-dihydroxy-2,3,4,5-tetramethoxy-xanthone (HM-4) and 1,5-dihydroxy-2,3-dimethoxy-xanthone (HM-5), were studied in rat liver microsomes in vitro. High performance liquid chromatography coupled to ion trap time-of-flight mass spectrometry (LC-ESI-IT-TOF) was applied for identification of metabolites of five xanthones mentioned above and (1)H NMR was used to elucidate the major metabolites. The structures of thirteen metabolites were identified and seven of them had not been reported before. Moreover, xanthone isomers herein could be distinguished by difference of fragmentation behaviors with increase of stages or relative abundances. The results indicated that in vitro metabolic transformation of HM-1, HM-2, HM-3, HM-4 and HM-5 occurred mainly at 2-, 4-, 5-, 7-carbonic positions on their structures of parent drugs. The metabolites could be new vasoactive substances. This work will provide a basis for study on the structure-activity relationships of these xanthones and their derivatives from Tibetan herbal in the next work.

Crystal Structure of 1-Hydroxy-2,3,4,7-tetramethoxyxanthone, a Xanthone Isolated from Halenia Elliptica

[Xanthone Glycosides from Tibetan Herb Halenia Elliptica].

[Xanthones from Tibetan Medicine Halenia Elliptica and Their Antioxidant Activity].

Crystal Structure of 1,5,8-Trihydroxyl-3-methoxy Xanthone from Swertia Chirayita

Synthesis and crystal structure of 3,3,6,6-tetramethyl- 4a-hydroxy-9-orthomethoxyphenyl-1, 8-dioxo-2,3,4,4a,5,6,7,8,9, 9a-decahydro-1H-xanthene

Isolation and Crystal Structure of Xanthones from Swertia Chirayita

Synthesis and crystal structure of 3, 3-dimethyl-9-(5,5- dimethyl-3-hydroxy-2-cyclohexen-1-one-2-yl)-1-oxo-2, 3, 4, 9-tetrahydroxanthene

2-Hydroxy-1-methoxyxanthen-9-one monohydrate

Synthesis and crystal Structure of 3,3,6,6,-tetramethyl-9-orthochlorophenyl-1,8-dioxo-3,4,5,6,7,9-hexahydroxanthene

1-Hydroxy-2,3,4,7-tetramethoxyxanthone from Swertia Chirayita

Crystal Structure of 10A-Hydroxy-9-(3-nitrophenyl)-3,6-diphenyl-3,4,5,6,7,8a,9,10a-octahydro-1h-xanthene-1,8(2h)-dione

4&#946;-Hydroxy-12,13-epoxytrichothec-9-ene

In vitro study on metabolite profiles of bioactive xanthones isolated from Halenia elliptica D. Don by high performance liquid chromatography coupled to ion trap time-of-flight mass spectrometry.

One-Step Isolation and Purification of Four Xanthone Glycosides from Tibetan Medicinal PlantHalenia Ellipticaby High-Speed Counter-Current Chromatography

5,6,7,5&#8242;-Tetramethoxy-3&#8242;,4&#8242;-methylenedioxyflavone monohydrate

(E)-2-meth-oxy-9-(2-meth-oxy-9h-xanthen-9-yl-idene)-9h-xanthene.

Structural Elucidation On A Triterpenic Heptaglycoside From Kalopanax Septemlobus

9-(4-Chloro-phen-yl)-4a-hy-droxy-4,4a,5,6,9,9a-hexa-hydro-3H-xanthene-1,8(2H,7H)-dione.

Synthesis And Crystal Structure Of 3,3,6,6-Tetramethyl-9-(4-Chlorophenyl)-1,8-Dioxo-2,3,4,5,6,7-Hexahydroxa Nthene

Crystal structure of anthraquinone-2-carboxylic acid, C 15 H 8 O 4

Crystal structure of (1 E ,3 E ,5 E )-1,6-bis(4-(pentyloxy)phenyl)hexa-1,3,5-triene, C 28 H 36 O 2